1144 related articles for article (PubMed ID: 15543575)
21. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.
Subtirelu MM; Flynn JT; Schechner RS; Pullman JM; Feuerstein D; Del Rio M
Pediatr Transplant; 2005 Dec; 9(6):801-4. PubMed ID: 16269055
[TBL] [Abstract][Full Text] [Related]
22. Persistence of parvovirus B19 IgM antibodies and DNA in pure red cell aplasia resulting in myelodysplasia--a case report.
Kishore J; Mukhopadhyay C
Indian J Pathol Microbiol; 2004 Jan; 47(1):78-81. PubMed ID: 15471143
[TBL] [Abstract][Full Text] [Related]
23. Human parvovirus B19 in patients with aplastic anemia.
Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N
Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106
[TBL] [Abstract][Full Text] [Related]
24. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
25. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients.
Ki CS; Kim IS; Kim JW; Lee NY; Kim SH; Lee KW; Kim SJ; Joh JW; Huh WS; Oh HY
Clin Transplant; 2005 Dec; 19(6):751-5. PubMed ID: 16313320
[TBL] [Abstract][Full Text] [Related]
26. [Congenital aplastic anemia caused by parvovirus B19 infection].
Vepreková L; Jelínek J; Zeman J
Cas Lek Cesk; 2001 Mar; 140(6):178-80. PubMed ID: 11347208
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
[TBL] [Abstract][Full Text] [Related]
28. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy.
Lindblom A; Heyman M; Gustafsson I; Norbeck O; Kaldensjö T; Vernby A; Henter JI; Tolfvenstam T; Broliden K
Clin Infect Dis; 2008 Feb; 46(4):528-36. PubMed ID: 18194100
[TBL] [Abstract][Full Text] [Related]
29. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
[TBL] [Abstract][Full Text] [Related]
30. Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA.
Donoso Mantke O; Nitsche A; Meyer R; Klingel K; Niedrig M
J Clin Virol; 2004 Sep; 31(1):32-9. PubMed ID: 15288611
[TBL] [Abstract][Full Text] [Related]
31. B19 virus infection in renal transplant recipients.
Cavallo R; Merlino C; Re D; Bollero C; Bergallo M; Lembo D; Musso T; Leonardi G; Segoloni GP; Ponzi AN
J Clin Virol; 2003 Apr; 26(3):361-8. PubMed ID: 12637086
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
[TBL] [Abstract][Full Text] [Related]
33. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.
Koppelman MH; Rood IG; Fryer JF; Baylis SA; Cuypers HT
Vox Sang; 2007 Oct; 93(3):208-15. PubMed ID: 17845257
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors.
Zadsar M; Aghakhani A; Banifazl M; Kazemimanesh M; Tabatabaei Yazdi SM; Mamishi S; Bavand A; Sadat Larijani M; Ramezani A
J Med Virol; 2018 Aug; 90(8):1318-1322. PubMed ID: 29663448
[TBL] [Abstract][Full Text] [Related]
35. Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia.
Seishima M; Mizutani Y; Shibuya Y; Arakawa C
Dermatology; 2008; 216(4):341-6. PubMed ID: 18277075
[TBL] [Abstract][Full Text] [Related]
36. Recurrent anemia in kidney transplant recipients with parvovirus B19 infection.
Renoult E; Bachelet C; Krier-Coudert MJ; Diarrassouba A; André JL; Kessler M
Transplant Proc; 2006 Sep; 38(7):2321-3. PubMed ID: 16980079
[TBL] [Abstract][Full Text] [Related]
37. Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease.
Katragadda L; Shahid Z; Restrepo A; Muzaffar J; Alapat D; Anaissie E
Transpl Infect Dis; 2013 Aug; 15(4):354-60. PubMed ID: 23578205
[TBL] [Abstract][Full Text] [Related]
38. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
39. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
Işik N; Ağaçfidan A; Ağirbaşli H; Işik DM; Bozkaya E; Gedikoğlu G; Badur S
Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265
[TBL] [Abstract][Full Text] [Related]
40. Impact of Parvovirus B19 Viremia in Liver Transplanted Children on Anemia: A Retrospective Study.
Würdinger M; Modrow S; Plentz A
Viruses; 2017 Jun; 9(6):. PubMed ID: 28608818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
